Therapeutic Asset Ratings
311 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
VINBLASTINE
Classic Hodgkin Lymphoma
University of Washington
P3
BB
(65)
Dostarlimab
Stage IV Pancreatic Cancer AJCC v8
University of Washington
P2
BB
(65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Gray Zone Lymphoma
University of Washington
P2
BB
(65)
Nivolumab
Recurrent Mantle Cell Lymphoma
University of Washington
P2
BB
(65)
Nivolumab
Recurrent Marginal Zone Lymphoma
University of Washington
P2
BB
(65)
Sargramostim
Locally Advanced Lung Non-Small Cell Carcinoma
University of Washington
P2
BB
(65)
(+)-VINCRISTINE
Recurrent B Lymphoblastic Lymphoma
University of Washington
P2
BB
(65)
(+)-VINCRISTINE
Refractory B Lymphoblastic Lymphoma
University of Washington
P2
BB
(65)
Inno-206
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
University of Washington
P2/3
BB
(65)
PREDNISONE TABLETS
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
University of Washington
P2/3
BB
(65)
FES F-18
Stage IV Breast Cancer AJCC v6 and v7
University of Washington
P3
BB
(64)
PREDNISONE TABLETS
Lymphoblastic Lymphoma
University of Washington
P3
BB
(64)
ETOPOSIDE
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
University of Washington
P2
BB
(64)
ETOPOSIDE
Gray Zone Lymphoma
University of Washington
P2
BB
(64)
FILGRASTIM
Lymphoblastic Lymphoma
University of Washington
P2
BB
(64)
FLUTICASONE
Lung Cancer
University of Washington
P2
BB
(64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Recurrent T Acute Lymphoblastic Leukemia
University of Washington
P2
BB
(64)
Inno-206
Gray Zone Lymphoma
University of Washington
P2
BB
(64)
Mitoxantrone
Mixed Lineage Acute Leukemia
University of Washington
P2
BB
(64)
Polatuzumab Vedotin
Indolent B-Cell Non-Hodgkin Lymphoma
University of Washington
P2
BB
(64)
PREDNISONE TABLETS
Gray Zone Lymphoma
University of Washington
P2
BB
(64)
Sargramostim
Triple-Negative Breast Carcinoma
University of Washington
P2
BB
(64)
Venetoclax
Acute Biphenotypic Leukemia
University of Washington
P2
BB
(64)
Cyclophosphamide
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
University of Washington
P2/3
BB
(64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
University of Washington
P2/3
BB
(64)
Showing 51 to 75 of 311 assets
Previous
Page 3 of 13
Next